SG10202101479PA - Peptides with vasodilatory and/or diuretic functions - Google Patents
Peptides with vasodilatory and/or diuretic functionsInfo
- Publication number
- SG10202101479PA SG10202101479PA SG10202101479PA SG10202101479PA SG10202101479PA SG 10202101479P A SG10202101479P A SG 10202101479PA SG 10202101479P A SG10202101479P A SG 10202101479PA SG 10202101479P A SG10202101479P A SG 10202101479PA SG 10202101479P A SG10202101479P A SG 10202101479PA
- Authority
- SG
- Singapore
- Prior art keywords
- vasodilatory
- peptides
- diuretic
- functions
- diuretic functions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201606879W | 2016-08-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202101479PA true SG10202101479PA (en) | 2021-03-30 |
Family
ID=61196932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901226RA SG11201901226RA (en) | 2016-08-18 | 2017-08-18 | Peptides with vasodilatory and/or diuretic functions |
| SG10202101479PA SG10202101479PA (en) | 2016-08-18 | 2017-08-18 | Peptides with vasodilatory and/or diuretic functions |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901226RA SG11201901226RA (en) | 2016-08-18 | 2017-08-18 | Peptides with vasodilatory and/or diuretic functions |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11312758B2 (en) |
| EP (2) | EP4403566A3 (en) |
| JP (1) | JP2019528067A (en) |
| CN (1) | CN109843912B (en) |
| SG (2) | SG11201901226RA (en) |
| WO (1) | WO2018034622A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY38747A (en) | 2019-06-12 | 2021-01-29 | Novartis Ag | NATRIURETIC 1 PEPTIDE RECEPTOR ANTIBODIES AND METHODS OF USE |
| US20240174727A1 (en) | 2022-10-21 | 2024-05-30 | Eli Lilly And Company | Long-acting natriuretic peptides and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5665704A (en) * | 1993-11-12 | 1997-09-09 | Genentech, Inc. | Receptor specific atrial natriuretic peptides |
| US6525022B1 (en) * | 1993-11-12 | 2003-02-25 | Genentech, Inc. | Receptor specific atrial natriuretic peptides |
| US6407211B1 (en) * | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
| US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
| DE602005026014D1 (en) | 2004-07-15 | 2011-03-03 | Univ Queensland | PROTEIN-type compounds and applications thereof |
| WO2009149161A2 (en) * | 2008-06-06 | 2009-12-10 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling |
| CA2823066A1 (en) | 2010-12-27 | 2012-07-05 | Alexion Pharma International Sarl | Compositions comprising natriuretic peptides and methods of use thereof |
| WO2012099258A1 (en) * | 2011-01-21 | 2012-07-26 | 株式会社 イギス | Therapeutic agent for alopecia |
| WO2013032784A1 (en) | 2011-08-30 | 2013-03-07 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides |
| WO2014209229A1 (en) * | 2013-06-25 | 2014-12-31 | National University Of Singapore | Vasodilation peptides and uses thereof |
-
2017
- 2017-08-18 SG SG11201901226RA patent/SG11201901226RA/en unknown
- 2017-08-18 US US16/325,928 patent/US11312758B2/en active Active
- 2017-08-18 SG SG10202101479PA patent/SG10202101479PA/en unknown
- 2017-08-18 EP EP24169434.8A patent/EP4403566A3/en active Pending
- 2017-08-18 CN CN201780063524.7A patent/CN109843912B/en active Active
- 2017-08-18 JP JP2019509532A patent/JP2019528067A/en active Pending
- 2017-08-18 EP EP17841768.9A patent/EP3500592B1/en active Active
- 2017-08-18 WO PCT/SG2017/050411 patent/WO2018034622A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3500592A4 (en) | 2020-08-12 |
| SG11201901226RA (en) | 2019-03-28 |
| EP4403566A3 (en) | 2024-08-21 |
| CN109843912B (en) | 2023-04-04 |
| EP3500592A1 (en) | 2019-06-26 |
| EP3500592B1 (en) | 2024-05-29 |
| JP2019528067A (en) | 2019-10-10 |
| US20190211071A1 (en) | 2019-07-11 |
| WO2018034622A1 (en) | 2018-02-22 |
| EP4403566A2 (en) | 2024-07-24 |
| CN109843912A (en) | 2019-06-04 |
| US11312758B2 (en) | 2022-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285286A (en) | Transposase polypeptides and uses thereof | |
| IL273327A (en) | Chimeric polypeptides and uses thereof | |
| IL257706A (en) | Peptidomimetic macrocycles and uses thereof | |
| IL254444A0 (en) | Peptidomimetic macrocycles and uses thereof | |
| IL268593A (en) | Polypeptide variants and uses thereof | |
| ZA201708218B (en) | Recombinant yeast and use thereof | |
| EP3536792A4 (en) | Recombinant yeast and use thereof | |
| HK1247111A1 (en) | Polypeptide therapeutics and uses thereof | |
| HK1248729A1 (en) | Cytotoxic hexim1 peptides and uses thereof | |
| IL280808A (en) | Ox40-binding polypeptides and uses thereof | |
| SG11202006669RA (en) | Peptides and uses thereof | |
| GB201819200D0 (en) | Polypeptide and uses thereof | |
| ZA201902093B (en) | Variant type iii interferons and synthekines | |
| ZA201901942B (en) | Nnif and nnif-related peptides and related methods | |
| EP3649146C0 (en) | Apelin peptides and uses thereof | |
| EP3480212C0 (en) | Il13ralpha2 peptide and its uses | |
| SG10202101479PA (en) | Peptides with vasodilatory and/or diuretic functions | |
| EP3389784A4 (en) | Short synthetic peptide and uses thereof | |
| ZA201807471B (en) | Variant polypeptides with improved performance and use of the same | |
| EP3684796A4 (en) | Succinate-regulating polypeptides and use thereof | |
| EP3611181A4 (en) | Atp1a1-targeting polypeptide and use | |
| PT3250234T (en) | Recombinant mdv1 and the uses thereof | |
| GB201812328D0 (en) | Polypeptides and uses thereof | |
| GB201712268D0 (en) | Polypeptides and uses thereof | |
| GB201712266D0 (en) | polypeptides and uses thereof |